Literature DB >> 9728596

The roles of human viruses in the pathogenesis of lymphoma.

S F Lyons1, D N Liebowitz.   

Abstract

There are two families of viruses that contribute to lymphomagenesis in humans: herpesviruses and retroviruses. The two herpesviruses are the Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV-8). EBV is an extremely well-characterized transforming agent: nine viral proteins contribute to transformation in vitro. In contrast, in vivo, the pattern of EBV gene expression varies with different types of malignancies. EBV is associated with endemic Burkitt's lymphoma, acquired immune deficiency syndrome (AIDS)-related lymphoma, post-transplantation lymphoproliferative disease, Hodgkin's disease (HD), and rare T-cell lymphomas. We have summarized studies on the different patterns of viral gene expression and signaling in different EBV-related malignancies, which have begun to reveal how EBV variably contributes to the malignant phenotype in different diseases. HHV-8 is associated with primary effusion lymphomas in patients with AIDS, and the rapidly accumulating information on this virus is summarized. Human T-cell leukemia virus-1 (HTLV-1) is a retrovirus which is the causative agent of adult T-cell leukemia/lymphoma (ATL). The specific mechanism of HTLV-1-mediated T-cell transformation is unclear, but the effects of HTLV-1 on interleukin-2 signaling are reviewed.

Entities:  

Mesh:

Year:  1998        PMID: 9728596

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  13 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

Review 3.  Complement receptors and the shaping of the natural antibody repertoire.

Authors:  V Michael Holers
Journal:  Springer Semin Immunopathol       Date:  2004-12-22

4.  Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.

Authors:  John P Graham; Carissa R Moore; Gail A Bishop
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

5.  Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.

Authors:  Craig S Miller; Sergei A Avdiushko; Richard J Kryscio; Robert J Danaher; Robert J Jacob
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 6.  Multimodality imaging findings of infection-induced tumors.

Authors:  Moataz Soliman; Nicholas Guys; Peter Liu; Mariam Moshiri; Christine O Menias; Vincent M Mellnick; Hatice Savas; Mohamed Badawy; Khaled M Elsayes; Ayman H Gaballah
Journal:  Abdom Radiol (NY)       Date:  2022-09-07

7.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

8.  TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1.

Authors:  Kelly M Arcipowski; Gail A Bishop
Journal:  J Immunol       Date:  2012-10-29       Impact factor: 5.422

Review 9.  Signaling by CD40 and its mimics in B cell activation.

Authors:  G A Bishop; B S Hostager
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

10.  Virus-associated lymphomagenesis.

Authors:  V Z Tarantul
Journal:  Int J Biomed Sci       Date:  2006-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.